Sensitive bromatometric assay methods for finasteride in pharmaceuticals
PDF

Keywords

finasteride
spectrophotometry
bromate-bromide
dyes
tablets

How to Cite

Kanakapura, B., Somashekar, B. C., Anilkumar, U. R., & Ramakrishna, V. (2006). Sensitive bromatometric assay methods for finasteride in pharmaceuticals. Eclética Química, 31(3), 31–38. https://doi.org/10.26850/1678-4618eqj.v31.3.2006.p31-38

Abstract

Three sensitive spectrophotometric methods are presented for the determination of finas-
teride in bulk and in tablets. The methods rely on the use of bromate-bromide reagent and three dyes
namely, methyl orange, indigocarmine and thymol blue as reagents. They involve the addition of a
measured excess of bromate-bromide reagent to finasteride in acid medium, and after the bromination
reaction is judged to be complete, the unreacted bromine is determined by reacting with a fixed amount
of either methylorange and measuring the absorbance at 520 nm (method A) or indigocarmine and
measuring the absorbance at 610 nm (method B) or thymol blue and measuring the absorbance at 550
nm (method C). In all the methods, the amount of insitu generated bromine reacted corresponds to the
amount of finasteride. The absorbance measured at the respective wavelength is found increase linear-
ly with the concentration of finasteride. Beer’s law is obeyed in the ranges 0.25- 2.0, 0.5-6.0 and 1-12
μg mL -1 for method A, method B and method C, respectively.

https://doi.org/10.26850/1678-4618eqj.v31.3.2006.p31-38
PDF

References

The Merck Index, 12 th Edn., Merck and Co. Inc, White

House Station. N J, 691, (1994).

Current Index of Medical Specialities (CIMS), Updated

Prescriber’s Hand Book, July-October 2005, PP.288,

CMPMedia India Pvt. Ltd., Bangalore, India.

G. Carlucci, P. Mazzeo, J. Chromatogr.-B: Biomed. Appl.

(1997) 245.

B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng.,

Anal. Chem. 70 (1998) 882.

T. Takano, S. Hata, J. Chromatogr. B: Biomed. Appl. 676

(1996) 141.

M.L. Constanzer, C.M. Chavez, B.K. Matuszewski, J.

Chromatogr. B: Biomed. Appl. 658 (1994) 281.

Yuquin, Y. Yang, L. Huichen, Yaowu Fenxi Zazhi 25 (2005)

X. Yuquing, L.Yanyan, Zhongguo Yaoke Daxue Xuebao 35

(2004) 187.

Zhiyong, C. Xiaoyan, Z.Yifan, Z. Dafang, Zhongguo

Linchuang Yaolixue Zazhi 19 (2003) 196.

L. Xiangyang, D, Li, L. Limin, Yaoxue Xuebao, 38 (2003)

P. Ptacek, J. Macek, J. Klima, J. Chromatogr, B: Biomed.

Sci. Appl., 738 (2000) 305.

L. Xiyang, C. Yifeng, C. Wansheng, Z. Bin, Z. Dong

Liang, Yaowu Fenxi Zazhi, 23 (2003) 46.

X. Mufeng, Zhongguo Yiyao Gongye Zazhi, 33 (2002)

M. F. Vitate, V.L. Perez, M. L. Palacios, M. T. Pizzorno, J.

Liq. Chromatogr. Relat. Technol., 25 (2002) 3167.

L. Xin-yuan, S. Yu-xin, Hebei Gongue Daxue Xuebao, 30

(2001) 66.

D. Hulya, C. Aysen, S. Serap, Anal. Chimica Acta, 557(1-

(2006) 252.

Z. Li, L. Luosheng, L. Fengli, Yaowu Fenxi Zazhi, 22

(2002) 456.

H. Rongfeng, F. Zhiying, W. Jian, S. Song, Zhongguo

Yiyuan Yaoxue, 22 (2002) 287.

A. A. Syed, M. K. Amshumali, J. Pharm. Biomed. Anal.,

(2001) 1015.

K. Ilango, P. Valentina, K.S.Lakshmi, Indian Drugs, 40

(2003) 122.

S. N. Meyyanathan, G.V.S. Ramasarma, B. Suresh, J.

Planar Chromatogr-Mod. TLC., 14 (2001) 188.

J.A. Ryan, S.V. Compton, M.A. Brooks, D.A.C.Compton,

J. Pharm. Biomed. Anal., 9 (1991) 303.

S.M. Amer, Farmaco, 58 (2003) 159.

Martindale, The Extrapharmacopoeia, 30th Edn; The

pharmaceutical Press London. (1994) 691

The United States of Pharmacopeia. United States

Pharamcopoeial Convention Inc., Rockville. 29 (2005) 907.

K. Ilango, P. Valentina, K.S. Lakshmi; Indian J. Pharm.

Sci., 64, (2002).174.

K. Basavaiah, H.C. Prameela, Science Asia, 29 (2003)

K. Basavaiah, H.C. Prameela, Anal. Bioanal.Chem., 29

(2003) 25.

Planar Chromatogr-Mod. TLC., 14 (2001) 188.

J.A. Ryan, S.V. Compton, M.A. Brooks, D.A.C.Compton,

J. Pharm. Biomed. Anal., 9 (1991) 303.

S.M. Amer, Farmaco, 58 (2003) 159.

Martindale, The Extrapharmacopoeia, 30th Edn; The

pharmaceutical Press London. (1994) 691

The United States of Pharmacopeia. United States

Pharamcopoeial Convention Inc., Rockville. 29 (2005) 907.

K. Ilango, P. Valentina, K.S. Lakshmi; Indian J. Pharm.

Sci., 64, (2002).174.

K. Basavaiah, H.C. Prameela, Science Asia, 29 (2003)

K. Basavaiah, H.C. Prameela, Anal. Bioanal.Chem., 29

(2003) 25.

K. Basavaiah, U. Chadrashekar, Acta Ciencia Indica

Chem., 29 (2003) 25.

. K. Basavaiah, P. Nagegowda, IL Farmaco, 59 (2004) 147.

. K. Basavaiah, P. Nagegowda, Oxid. Commun., 27 (2004)

. K. Basavaiah, H.C. Prameela, Indian J. Pharm. Sci., 67

(2004) 883.

. K. Basavaiah, Indian J. Chem. Technol., 12 (2005) 149.

. K. Basavaiah, P. Nagegowda, J. Braz. Chem. Soc., 16

(2005) 821.

. K. Basavaiah, B.C. Somashekar, Indian J. Chem.

Technol., 12 (2006) 316.

. Text on Validation of Analytical Procedures, ICH

Harmonized Tripartite Guideline,6. (1994).

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2018 Eclética Química Journal

Metrics

PDF views
75
Jan 2007Jul 2007Jan 2008Jul 2008Jan 2009Jul 2009Jan 2010Jul 2010Jan 2011Jul 2011Jan 2012Jul 2012Jan 2013Jul 2013Jan 2014Jul 2014Jan 2015Jul 2015Jan 2016Jul 2016Jan 2017Jul 2017Jan 2018Jul 2018Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20266.0
|